Skip to main content

Clinical and Translational Oncology

Ausgabe 3/2023

Inhalt (28 Artikel)

Open Access Review Article

MiR-29a-3p: a potential biomarker and therapeutic target in colorectal cancer

Wen-Yan Mo, Shi-Qiong Cao

Review Article

Roles of oncogenes in esophageal squamous cell carcinoma and their therapeutic potentials

Shuai Xiao, Guo Huang, Weihong Zeng, Jun Zhou, Yukun Li, Tingyu Fan, Xiaomin Liu, Jiliang Xia, Xi Zeng

Review Article

The diagnostic role and mechanistic functions of exosomal lncRNAs in prostate cancer

Hangsheng Zhou, Hongyuan Wan, Yanyan Feng, Lijie Zhu, Yuanyuan Mi

Review Article

Leptin signaling in breast cancer and its crosstalk with peroxisome proliferator-activated receptors α and γ

Nasim Dana, Gordon A. Ferns, Reza Nedaeinia, Shaghayegh Haghjooy Javanmard

Review Article

The role of long non-coding RNA HCG18 in cancer

Zhiqiang Wang, Rui Ran, Shunbai Zhang, Wenming Zhou, Jiayang Lv, Chunwei Ma, Haihong Zhang

Review Article

The crosstalk between intestinal bacterial microbiota and immune cells in colorectal cancer progression

Xiaozi Wen, Xufang Ye, Xuejun Yang, Rujin Jiang, Chunyan Qian, Xianjun Wang

Special Article

The need for evolution in the management of febrile neutropenia in pediatric cancer: TRIIO KIDS update

Maria Luisa Navarro, Montserrat Nieto, Antonio Perez-Martínez

Open Access Research Article

Construction of miRNA–mRNA networks for the identification of lung cancer biomarkers in liquid biopsies

Elena Espinosa Garcia, Macarena Arroyo Varela, Rafael Larrosa Jimenez, Josefa Gomez-Maldonado, Manuel Angel Cobo Dols, M. Gonzalo Claros, Rocio Bautista Moreno

Research Article

The mechanism of VCP-mediated metastasis of osteosarcoma based on cell autophagy and the EMT pathway

An An Li, Yu Zhang, Fan Li, Yang Zhou, Zhi li Liu, Xin Hua Long

Research Article

STAT3 inhibitor BBI608 reduces patient-specific primary cell viability of cervical and endometrial cancer at a clinical-relevant concentration

Jing Chen, Shuting Huang, Huawen Li, Yun Li, Haishan Zeng, Jiemei Hu, Yanchun Lin, Huihua Cai, Pengfei Deng, Ting Song, Tian Guan, Haoyu Zeng, Mubiao Liu

Research Article

Molecular mechanism of XB130 adaptor protein mediates trastuzumab resistance in gastric cancer

Shengnan Yang, Binbin Wang, Jiaqi Liao, Ziyang Hong, Xuxian Zhong, Suling Chen, Ziqing Wu, Xingyu Zhang, Qiang Zuo

Research Article

CD155 is a putative therapeutic target in medulloblastoma

Sean Li, Roger McLendon, Eric Sankey, Reb Kornahrens, Anne-Marie Lyne, Florence Marie Géraldine Cavalli, Zachary McKay, James Emmett Herndon II, Marc Remke, Daniel Picard, Matthias Gromeier, Michael Brown, Eric Michael Thompson

Open Access Research Article

miRNA-576-5p promotes endometrial cancer cell growth and metastasis by targeting ZBTB4

Chen Chen, Qing Zhang, Beihua Kong

Research Article

Actual over 3-year survival after stereotactic body radiation therapy in patients with unresectable intrahepatic cholangiocarcinoma

Xiao-xue Zhang, Hong-bin Ma, Tie-hua Li, Bin Huang, Ning-yang Jia, Yan Meng

Research Article

miR-378a-3p promotes renal cell carcinoma proliferation, migration, and invasion by targeting TOB2

Nan Bao, Pengjie Zhang, Yanting Zhu, Peng Du, Gang Jin, Bing Wu, Tong Ding

Research Article

Urine-derived exosomal PSMA is a promising diagnostic biomarker for the detection of prostate cancer on initial biopsy

Cheng-Bang Wang, Shao-Hua Chen, Lin Zhao, Xin Jin, Xi Chen, Jin Ji, Zeng-Nan Mo, Fu-Bo Wang

COVID-19 Research Article

SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry

Maria Gonzalez-Cao, Teresa Puertolas, Clara Martinez-Vila, Cristina Carrera, Cayetana Maldonado Seral, Pedro Rodríguez-Jiménez, Silvia Sequero, Pablo Cerezuela-Fuentes, Rosa Feltes Ochoa, Eva Muñoz, Mónica Antoñanzas Basa, Juan Martín-Liberal, Ainara Soria, Juan Francisco Rodriguez Moreno, Ivan Marquez-Rodas, Pilar Lopez Criado, José Luis Manzano, Rafael Lopez-Castro, Pablo Ayala de Miguel, Laura Villalobos, Salvador Martin Algarra, Ines Gonzalez-Barrallo, Aram Boada, Almudena García Castaño, Susana Puig, Guillermo Crespo, Pablo Luna Fra, Cristina Aguayo Zamora, Marta Feito Rodríguez, Lara Valles, Ana Drozdowskyj, Jesús Gardeazabal, Luis Antonio Fernandez-Morales, Alberto Rodrigo, Raquel Cruz, Oriol Yelamos, Belen Rubio, Karmele Mujica, Mariano Provencio, Alfonso Berrocal

Open Access Research Article

Asparaginyl endopeptidase contributes to cetuximab resistance via MEK/ERK signaling in RAS wide-type metastatic colorectal cancer

Xiaojing Xu, Mengling Liu, Ke Peng, Yiyi Yu, Tianshu Liu

Research Article

Haematological and renal toxicity of radiation therapy in neuroblastoma paediatric patients

Elías Gomis Sellés, Blas David Delgado León, Patricia Cabrera Roldán, Catalina Márquez Vega, Eleonor Rivin del Campo, José Luis López Guerra

Open Access Research Article

Current professional standing of young medical oncologists in Spain: a nationwide survey by the Spanish Society of Medical Oncology + MIR section

Domingo Antonio Sanchez Martinez, Aliica Quilez-Cutillas, Pablo Jimenez-Labaig, Andrea Sesma, Noelia Tarazona, Vilma Pacheco-Barcia, Berta Obispo, David Paez, Teresa Quintanar, Manuel Sanchez-Canovas, Ana Fernandez Montes, Enriqueta Felip, Alvaro Rodriguez-Lescure, Elena Elez

Research Article

Tumor-suppressive miR-29c binds to MAPK1 inhibiting the ERK/MAPK pathway in pancreatic cancer

Hongtao Si, Ning Zhang, Chang Shi, Zhanjiang Luo, Senlin Hou

Open Access Research Article

The prognostic role of p53 and its correlation with CDK9 in urothelial carcinoma

Jędrzej Borowczak, Krzysztof Szczerbowski, Mateusz Maniewski, Marek Zdrenka, Piotr Słupski, Hanna Andrusewicz, Joanna Łysik-Miśkurka, Paula Rutkiewicz, Magdalena Bodnar, Łukasz Szylberg

Research Article

Suppression of CD56bright NK cells in breast cancer patients is associated with the PD-1 and TGF-βRII expression

Elaheh Arianfar, Seyed Reza Khandoozi, Saeed Mohammadi, Ali Memarian

ACKNOWLEDGEMENT TO REVIEWERS

Acknowledgement to reviewers 2022

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.